Murine Borrelia arthritis is highly dependent on ASC and caspase-1, but independent of NLRP3

Arthritis Research and Therapy

Volumn 14, Issue 6, 2012, Pages

  Oosting, Marije ^a   Buffen, Kathrin ^a   Malireddi, Subbarao R K ^b   Sturm, Patrick ^a   Verschueren, Ineke ^a   Koenders, Marije I ^a   van de Veerdonk, Frank L ^a   van der Meer, Jos W M ^a   Netea, Mihai G ^a   Kanneganti, Thirumala Devi ^b   Joosten, Leo A B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; TOLL LIKE RECEPTOR 2; APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; CIAS1 PROTEIN, MOUSE; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88; PYCARD PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE;

ARTICLE; BIOPSY TECHNIQUE; BORRELIA BURGDORFERI; CYTOKINE PRODUCTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYME DISEASE; MACROPHAGE; PATELLA BIOPSY; PATHOGENESIS; RANK SUM TEST; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; 129 MOUSE; ANIMAL; ARTHRITIS; C57BL MOUSE; CELL CULTURE; FEMALE; GENETICS; HOST PATHOGEN INTERACTION; KNEE; KNOCKOUT MOUSE; L CELL LINE; METABOLISM; MICROBIOLOGY; MOUSE; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; ARTHRITIS; BLOTTING, WESTERN; BORRELIA BURGDORFERI; CARRIER PROTEINS; CASPASE 1; CELLS, CULTURED; FEMALE; HOST-PATHOGEN INTERACTIONS; INFLAMMASOMES; INTERLEUKIN-1BETA; KNEE JOINT; L CELLS (CELL LINE); LYME DISEASE; MACROPHAGES; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; TOLL-LIKE RECEPTOR 2;

EID: 84868660402     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4090     Document Type: Article

References (47)

1. Berende A, Oosting M, Kullberg BJ, Netea MG, Joosten LA. Activation of innate host defense mechanisms by Borrelia. Eur Cytokine Netw 2010, 21:7-18.
2. Cervantes JL, Dunham-Ems SM, La Vake CJ, Petzke MM, Sahay B, Sellati TJ, Radolf JD, Salazar JC. Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-{beta}. Proc Natl Acad Sci USA 2011, 108:3683-3688. 10.1073/pnas.1013776108, 3048123, 21321205.
3. Oosting M, Berende A, Sturm P, Ter Hofstede HJ, de Jong DJ, Kanneganti TD, Van der Meer JW, Kullberg BJ, Netea MG, Joosten LA. Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction. J Infect Dis 2010, 201:1849-1858. 10.1086/652871, 20441518.
4. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, Zachary JF, Kirschning CJ, Weis JJ. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol 2002, 168:348-355.
5. Wang G, Ma Y, Buyuk A, McClain S, Weis JJ, Schwartz I. Impaired host defense to infection and Toll-like receptor 2-independent killing of Borrelia burgdorferi clinical isolates in TLR2-deficient C3H/HeJ mice. FEMS Microbiol Lett 2004, 231:219-225. 10.1016/S0378-1097(03)00960-1, 14987768.
6. Schröder NW, Diterich I, Zinke A, Eckert J, Draing C, von Baehr V, Hassler D, Priem S, Hahn K, Michelsen KS, Hartung T, Burmester GR, Göbel UB, Hermann C, Schumann RR. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol 2005, 175:2534-2540.
7. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000, 97:13766-13771. 10.1073/pnas.250476497, 17650, 11095740.
8. Oosting M, Ter HH, Sturm P, Adema GJ, Kullberg BJ, Van der Meer JW, Netea MG, Joosten LA. TLR1/TLR2 heterodimers play an important role in the recognition of Borrelia spirochetes. PLoSOne 2011, 6:e25998.
9. Kawai T, Akira S. TLR signaling. Cell Death Differ 2006, 13:816-825. 10.1038/sj.cdd.4401850, 16410796.
10. Dennis VA, Dixit S, O'Brien SM, Alvarez X, Pahar B, Philipp MT. Live Borrelia burgdorferi spirochetes elicit inflammatory mediators from human monocytes via the Toll-like receptor signaling pathway. Infect Immun 2009, 77:1238-1245. 10.1128/IAI.01078-08, 2643645, 19139200.
11. Behera AK, Hildebrand E, Bronson RT, Perides G, Uematsu S, Akira S, Hu LT. MyD88 deficiency results in tissue-specific changes in cytokine induction and inflammation in interleukin-18-independent mice infected with Borrelia burgdorferi. Infect Immun 2006, 74:1462-1470. 10.1128/IAI.74.3.1462-1470.2006, 1418660, 16495516.
12. Petnicki-Ocwieja T, Defrancesco AS, Chung E, Darcy CT, Bronson RT, Kobayashi KS, Hu LT. Nod2 suppresses Borrelia burgdorferi mediated murine lyme arthritis and carditis through the induction of tolerance. PLoSOne 2011, 6:e17414.
13. Beck G, Habicht GS, Benach JL, Coleman JL, Lysik RM, O'Brien RF. A role for interleukin-1 in the pathogenesis of Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg A 1986, 263:133-136.
14. Habicht GS, Beck G, Benach JL. The role of interleukin-1 in the pathogenesis of Lyme disease. Ann NY Acad Sci 1988, 539:80-86. 10.1111/j.1749-6632.1988.tb31840.x, 3263828.
15. Miller LC, Lynch EA, Isa S, Logan JW, Dinarello CA, Steere AC. Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 1993, 341:146-148. 10.1016/0140-6736(93)90006-3, 8093746.
16. Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med 2005, 201:1355-1359. 10.1084/jem.20050640, 2213199, 15867089.
17. Eder C. Mechanisms of interleukin-1beta release. Immunobiology 2009, 214:543-553. 10.1016/j.imbio.2008.11.007, 19250700.
18. van D, Netea MG, Dinarello CA, Joosten LA. Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol 2011, 32:110-116. 10.1016/j.it.2011.01.003, 21333600.
19. Oosting M, van D, Kanneganti TD, Sturm P, Verschueren I, Berende A, Van der Meer JW, Kullberg BJ, Netea MG, Joosten LA. Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism. Eur J Immunol 2011, 41:172-181. 10.1002/eji.201040385, 21182088.
20. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998, 9:143-150. 10.1016/S1074-7613(00)80596-8, 9697844.
21. Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L, Ogura Y, Kawasaki A, Fukase K, Kusumoto S, Valvano MA, Foster SJ, Mak TW, Nuñez G, Inohara N. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003, 4:702-707. 10.1038/ni945, 12796777.
22. Kanneganti TD, Ozören N, Body-Malapel M, Amer A, Park JH, Franchi L, Whitfield J, Barchet W, Colonna M, Vandenabeele P, Bertin J, Coyle A, Grant EP, Akira S, Núñez G. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006, 440:233-236. 10.1038/nature04517, 16407888.
23. Kobayashi K, Inohara N, Hernandez LD, Galan JE, Nunez G, Janeway CA, Medzhitov R, Flavell RA. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002, 416:194-199. 10.1038/416194a, 11894098.
24. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G, Flavell RA. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005, 307:731-734. 10.1126/science.1104911, 15692051.
25. Shaw PJ, Lukens JR, Burns S, Chi H, McGargill MA, Kanneganti TD. Cutting edge: critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis. J Immunol 2010, 184:4610-4614. 10.4049/jimmunol.1000217, 3001131, 20368281.
26. Ganapamo F, Dennis VA, Philipp MT. Differential acquired immune responsiveness to bacterial lipoproteins in Lyme disease-resistant and -susceptible mouse strains. Eur J Immunol 2003, 33:1934-1940. 10.1002/eji.200323655, 12884859.
27. Brisson D, Baxamusa N, Schwartz I, Wormser GP. Biodiversity of Borrelia burgdorferi strains in tissues of Lyme disease patients. PLoSOne 2011, 6:e22926.
28. Li X, McHugh GA, Damle N, Sikand VK, Glickstein L, Steere AC. Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis. Arthritis Rheum 2011, 63:2238-2247. 10.1002/art.30384, 21590753.
29. Armstrong AL, Barthold SW, Persing DH, Beck DS. Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am J Trop Med Hyg 1992, 47:249-258.
30. Barthold SW, Beck DS, Hansen GM, Terwilliger GA, Moody KD. Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis 1990, 162:133-138. 10.1093/infdis/162.1.133, 2141344.
31. Balkhy HH, Heinzel FP. Endotoxin fails to induce IFN-gamma in endotoxin-tolerant mice: deficiencies in both IL-12 heterodimer production and IL-12 responsiveness. J Immunol 1999, 162:3633-3638.
32. Liu N, Belperron AA, Booth CJ, Bockenstedt LK. The caspase 1 inflammasome is not required for control of murine Lyme borreliosis. Infect Immun 2009, 77:3320-3327. 10.1128/IAI.00100-09, 2715671, 19487481.
33. Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, Newton K, Qu Y, Liu J, Heldens S, Zhang J, Lee WP, Roose-Girma M, Dixit VM. Non-canonical inflammasome activation targets caspase-11. Nature 2011, 479:117-121. 10.1038/nature10558, 22002608.
34. Broz P, Ruby T, Belhocine K, Bouley DM, Kayagaki N, Dixit VM, Monack DM. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 2012,
35. Kolly L, Karababa M, Joosten LA, Narayan S, Salvi R, Petrilli V, Tschopp J, van den Berg WB, So AK, Busso N. Inflammatory role of ASC in antigen-induced arthritis is independent of caspase-1, NALP-3, and IPAF. J Immunol 2009, 183:4003-4012. 10.4049/jimmunol.0802173, 19717512.
36. Ippagunta SK, Brand DD, Luo J, Boyd KL, Calabrese C, Stienstra R, Van de Veerdonk FL, Netea MG, Joosten LA, Lamkanfi M, Kanneganti TD. Inflammasome-independent role of apoptosis-associated speck-like protein containing a CARD (ASC) in T cell priming is critical for collagen-induced arthritis. J Biol Chem 2010, 285:12454-12462. 10.1074/jbc.M109.093252, 2852983, 20177071.
37. Joosten LA, Netea MG, Mylona E, Koenders MI, Malireddi RK, Oosting M, Stienstra R, van de Veerdonk FL, Stalenhoef AF, Giamarellos-Bourboulis EJ, Kanneganti TD, van der Meer JW. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1beta production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum 2010, 62:3237-3248. 10.1002/art.27667, 2970687, 20662061.
38. Fang R, Tsuchiya K, Kawamura I, Shen Y, Hara H, Sakai S, Yamamoto T, Fernandes-Alnemri T, Yang R, Hernandez-Cuellar E, Dewamitta SR, Xu Y, Qu H, Alnemri ES, Mitsuyama M. Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to streptococcus pneumoniae infection. J Immunol 2011, 187:4890-4899. 10.4049/jimmunol.1100381, 3197964, 21957143.
39. Ellebedy AH, Lupfer C, Ghoneim HE, DeBeauchamp J, Kanneganti TD, Webby RJ. Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59. Proc Natl Acad Sci USA 2011, 108:2927-2932. 10.1073/pnas.1012455108, 3041074, 21270336.
40. Taxman DJ, Holley-Guthrie EA, Huang MT, Moore CB, Bergstralh DT, Allen IC, Lei Y, Gris D, Ting JP. The NLR adaptor ASC/PYCARD regulates DUSP10, mitogen-activated protein kinase (MAPK), and chemokine induction independent of the inflammasome. J Biol Chem 2011, 286:19605-19616. 10.1074/jbc.M111.221077, 3103340, 21487011.
41. Ippagunta SK, Malireddi RK, Shaw PJ, Neale GA, Walle LV, Green DR, Fukui Y, Lamkanfi M, Kanneganti TD. The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization. Nat Immunol 2011, 12:1010-1016. 10.1038/ni.2095, 3178750, 21892172.
42. Taxman DJ, Zhang J, Champagne C, Bergstralh DT, Iocca HA, Lich JD, Ting JP. Cutting edge: ASC mediates the induction of multiple cytokines by Porphyromonas gingivalis via caspase-1-dependent and -independent pathways. J Immunol 2006, 177:4252-4256.
43. Bolz DD, Sundsbak RS, Ma Y, Akira S, Kirschning CJ, Zachary JF, Weis JH, Weis JJ. MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J Immunol 2004, 173:2003-2010.
44. Joosten LA, Koenders MI, Smeets RL, Heuvelmans-Jacobs M, Helsen MM, Takeda K, Akira S, Lubberts E, van de Loo FA, van den Berg WB. Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88. J Immunol 2003, 171:6145-6153.
45. Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2005, 52:2936-2946. 10.1002/art.21238, 16142712.
46. Nigrovic PA, Mannion M, Prince FH, Zeft A, Rabinovich CE, van Rossum MA, Cortis E, Pardeo M, Miettunen PM, Janow G, Birmingham J, Eggebeen A, Janssen E, Shulman AI, Son MB, Hong S, Jones K, Ilowite NT, Cron RQ, Higgins GC. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum 2011, 63:545-555. 10.1002/art.30128, 21280009.
47. Tran AP, Edelman J. Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout. Int J Rheum Dis 2011, 14:e33-e37. 10.1111/j.1756-185X.2011.01629.x, 21816011.